Literature DB >> 20513129

Daily alternating deferasirox and deferiprone therapy for "hard-to-chelate" beta-thalassemia major patients.

Manuela Balocco, Paola Carrara, Valeria Pinto, Gian Luca Forni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20513129     DOI： 10.1002/ajh.21711

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  9 in total

1.  Deferasirox and renal dysfunction in children.

Authors:  Sunil Bhandari; Shahina Daar
Journal:  Pediatr Nephrol       Date:  2012-08-15       Impact factor: 3.714

2.  Red blood cell alloimmunisation among Chinese patients with β-thalassaemia major in Taiwan.

Authors:  Yu-Hua Chao; Kang-Hsi Wu; Jang-Jih Lu; Mu-Chin Shih; Ching-Tien Peng; Ci-Wen Chang
Journal:  Blood Transfus       Date:  2012-06-28       Impact factor: 3.443

Review 3.  Renal complications of beta-thalassemia major in children.

Authors:  Ashraf Bakr; Youssef Al-Tonbary; Ghada Osman; Rasha El-Ashry
Journal:  Am J Blood Res       Date:  2014-09-05

4.  Recent advances in β-thalassemias.

Authors:  Antonio Cao; Paolo Moi; Renzo Galanello
Journal:  Pediatr Rep       Date:  2011-06-16

5.  Management of transfusional iron overload - differential properties and efficacy of iron chelating agents.

Authors:  Janet L Kwiatkowski
Journal:  J Blood Med       Date:  2011-09-21

Review 6.  Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions.

Authors:  Antoine N Saliba; Afif R Harb; Ali T Taher
Journal:  J Blood Med       Date:  2015-06-17

7.  Assessment of Subclinical Renal Glomerular and Tubular Dysfunction in Children with Beta Thalassemia Major.

Authors:  Asmaa A Mahmoud; Doaa M Elian; Nahla Ms Abd El Hady; Heba M Abdallah; Shimaa Abdelsattar; Fatma O Khalil; Sameh A Abd El Naby
Journal:  Children (Basel)       Date:  2021-02-03

8.  Treating thalassemia major-related iron overload: the role of deferiprone.

Authors:  Vasilios Berdoukas; Kallistheni Farmaki; Susan Carson; John Wood; Thomas Coates
Journal:  J Blood Med       Date:  2012-10-19

9.  Efficacy and safety of combined oral iron chelation therapy with deferasirox and deferiprone in a patient with beta-thalassemia major and persistent iron overload.

Authors:  Samin Alavi; Elham Sadeghi; Azin Ashenagar
Journal:  Blood Res       Date:  2014-03-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.